Clinical Trial Patient Screening via Genome Analysis

  • Overview

QIAGEN performs genome sequencing and analyzes the sequenced DNA to help identify patients who have variants of interest compared to a reference genome, and thus could have the protein that the cryo-EM and LAMMPS output have identified as being of interest. By speeding the identification of patients who have the right protein and thus meet the criteria for a clinical trial, this analysis can speed an important aspect of clinical trials, reduce trial costs, and lead to more effective targeted treatments with fewer undesirable side effects.